Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Melinda, Csenki"'
Autor:
Zsófia Engi, Ria Benkő, Gyöngyvér Soós, Délia Szok, Melinda Csenki, Emese Csüllög, Attila Balog, Dezső Csupor, Réka Viola, Péter Doró, Mária Matuz
Opioid use is well documented in several countries: some countries struggle with overuse, whereas others have almost no access to opioids. For Europe, limited data are available. This study analysed Hungarian opioid utilization in ambulatory care bet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::425d772b3e3d4d1164b8b5e4aac082bf
http://doi.org/10.1002/ejp.2011
http://doi.org/10.1002/ejp.2011
Autor:
Gabriella Uhercsák, Ágnes Dobi, Adrienne Cserháti, Alíz Nikolényi, Melinda Csenki, Orsolya Rusz, Renáta Kószó, Erzsébet Valicsek, Zsuzsanna Kahán
Publikováno v:
OncoTargets and therapy. 11
Orsolya Rusz, Renáta Kószó, Ágnes Dobi, Melinda Csenki, Erzsébet Valicsek, Alíz Nikolényi, Gabriella Uhercsák, Adrienne Cserháti, Zsuzsanna Kahán Department of Oncotherapy, University of Szeged, Szeged, Hungary Abstract: Fulvestrant is a pu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::306235b91863389b419ab5efdc2edce5
https://pubmed.ncbi.nlm.nih.gov/30233207
https://pubmed.ncbi.nlm.nih.gov/30233207
Autor:
Ervin Tánczos, Sándor Hamar, Zsuzsanna Kahán, Maria Wagnerova, Erika Csörgő, Gabriella Uhercsák, Thomas Brodowicz, Alíz Nikolényi, Melinda Csenki, László Thurzó
Publikováno v:
Pathology & Oncology Research. 18:61-68
There is a need for the selection of those breast cancers where benefit may be attained from the addition of an anthracycline to the adjuvant chemotherapy. The expression of topoisomerase II alpha (TOP2A) protein in 3 cohorts of breast cancers treate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0e212ccabde90d6cf0c94882f41a26f
https://doi.org/10.1007/s12253-011-9417-4
https://doi.org/10.1007/s12253-011-9417-4
Autor:
Attila Balogh, Elemér Szil, Melinda Csenki, Adrienn Cserháti, Zsuzsanna Kahán, Zsofia Gyulai, Zoltán Varga, Krisztina Boda, László Thurzó, Yvette Mándi
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 68:673-681
Purpose: To study the risks of early and late radiogenic lung damage in breast cancer patients after conformal radiotherapy. Methods and Materials: Radiogenic lung sequelae were assessed prospectively in 119 patients by means of clinical signs, radio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1c0420c28fbd64fffd94f65d2d8c3f7
https://doi.org/10.1016/j.ijrobp.2006.12.016
https://doi.org/10.1016/j.ijrobp.2006.12.016
Autor:
Katalin, Hideghéty, Adrienne, Cserháti, Zsuzsanna, Besenyi, Levente, Zag, Szilvia, Gaál, Zsófia, Együd, Petra, Mózes, Erika, Szántó, Melinda, Csenki, Orsolya, Rusz, Zoltán, Varga, Ágnes, Dobi, Anikó, Maráz, László, Pávics, Zsolt, Lengyel
Publikováno v:
Magyar onkologia. 59(2)
The purpose of our work is evaluation of the impact of 18FDG-PET/CT on the complex management of locoregionally advanced (T3-4N1-3) head and neck squamous cell cancer (LAHNSC), and on the target definition for 3D conformal (3DCRT) and intensity-modul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::047a241dd8334df1b04bcf5644c70e9f
https://pubmed.ncbi.nlm.nih.gov/26035157
https://pubmed.ncbi.nlm.nih.gov/26035157
Publikováno v:
Therapeutics and Clinical Risk Management
Melinda Csenki, Dóra Újhidy, Adrienn Cserháti, Zsuzsanna Kahán, Zoltán Varga Department of Oncotherapy, University of Szeged, Szeged, Hungary Background: Prone positioning for breast radiotherapy is preferable when the aim is a reduction of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97b08cfb30af4cd8927b7c7911662b84
https://www.dovepress.com/radiation-dose-to-the-nodal-regions-during-prone-versus-supine-breast--peer-reviewed-article-TCRM
https://www.dovepress.com/radiation-dose-to-the-nodal-regions-during-prone-versus-supine-breast--peer-reviewed-article-TCRM